Soleno Therapeutics, Inc. Class Action Lawsuit
Company: Soleno Therapeutics, Inc.
Ticker: (NASDAQ) SLNO
Class Action Period: March 26, 2025 - November 4, 2025
See If You Qualify For Monetary Reward
Join the Soleno Therapeutics, Inc. Class Action Lawsuit
CLASS ACTION PERIOD
March 26, 2025 - November 4, 2025
Allegations
The complaint filed against Soleno Therapeutics, Inc. alleges the company made statements that were materially false and/or misleading and/or failed to disclose that: (a) the Soleno Phase 3 clinical trial program for product diazoxide choline extended-release tablets, DCCR, had systematically downplayed, misrepresented, and/or concealed significant evidence of safety concerns potentially related to the administration of DCCR, including issues related to excess fluid retention in clinical trial participants; (b) as a result of (a) above, the administration of DCCR to treat hyperphagia in individuals with PWS posed materially greater safety risks than disclosed by the Company or its executives; and (c) as a result of (a)-(b) above, DCCR had materially lower commercial viability and undisclosed risks related to the likelihood of significant and widespread adverse events after its commercial launch, including risks related to patient discontinuation rates, lower patient adoption, prescriber reluctance, adverse regulatory action, and potential reputational and legal fallout.
Eligibility
To join the lawsuit, you must have experienced a loss on Soleno Therapeutics, Inc. shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Soleno Therapeutics, Inc. during the relevant time frame, you have until May 5, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Frequently Asked Questions
- How do I join the lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO)?
Investors who purchased shares of Soleno Therapeutics, Inc. (NASDAQ: SLNO) during the class period (March 26, 2025 - November 4, 2025) can join by submitting their transaction details through this case page.
- Ensure your purchase falls within the class period
- Provide basic transaction and loss details
- Submit your information before the deadline
The lead plaintiff deadline for this case is May 5, 2026, so investors should act quickly to protect their rights.
- Who is eligible for the Soleno Therapeutics, Inc. lawsuit?
Anyone who bought shares of Soleno Therapeutics, Inc. (NASDAQ: SLNO) during March 26, 2025 - November 4, 2025 and suffered financial losses may qualify.
- What is the lead plaintiff deadline to join the Soleno Therapeutics, Inc. case?
The lead plaintiff deadline for the Soleno Therapeutics, Inc. lawsuit is May 5, 2026. Investors should act quickly to avoid missing this deadline.
- What is the class period for Soleno Therapeutics, Inc.?
The class period for Soleno Therapeutics, Inc. (NASDAQ: SLNO) is March 26, 2025 - November 4, 2025, during which investors may have been affected by alleged misconduct.
- Can I still join the Soleno Therapeutics, Inc. lawsuit if I sold my shares?
Yes. Investors who purchased Soleno Therapeutics, Inc. shares during March 26, 2025 - November 4, 2025 may still qualify, even if they sold their shares later.
- How much compensation can I receive from the Soleno Therapeutics, Inc. lawsuit?
Compensation depends on the total losses and the final settlement. Eligible investors in the Soleno Therapeutics, Inc. case may receive a portion of the recovery.
- Do I need to pay to participate in the Soleno Therapeutics, Inc. case?
No, most securities fraud cases involving Soleno Therapeutics, Inc. operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.
- Will I need to appear in court for the Soleno Therapeutics, Inc. lawsuit?
In most cases, investors do not need to appear in court. The legal team manages the Soleno Therapeutics, Inc. case on behalf of participants.
- What documents are required for the Soleno Therapeutics, Inc. lawsuit?
To participate in the Soleno Therapeutics, Inc. lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.
- What happens after I submit my trade information for Soleno Therapeutics, Inc.?
After submission, your details for the Soleno Therapeutics, Inc. case will be reviewed, and you may be contacted regarding eligibility or next steps.
- Is this legal advice for the Soleno Therapeutics, Inc. lawsuit?
No, this page provides information about the Soleno Therapeutics, Inc. case and does not constitute legal advice or create an attorney-client relationship.
- Why should I act quickly on the Soleno Therapeutics, Inc. case?
The lead plaintiff deadline for the Soleno Therapeutics, Inc. lawsuit is May 5, 2026. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.
EXPLORE MORE CASES
Corcept Therapeutics Incorporated
CORT
Lead Plaintiff Deadline: April 21, 2026
Class Period: October 31, 2024 - December 30, 2025
Enphase Energy, Inc.
ENPH
Lead Plaintiff Deadline: April 20, 2026
Class Period: April 22, 2025 - October 28, 2025